Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
STANDARD LITHIUM LTD.
SIC 2800 · Chemicals & Allied Products
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
STANDARD LITHIUM LTD.
SIC 2800 · Chemicals & Allied Products
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
STANDARD LITHIUM LTD.
SIC 2800 · Chemicals & Allied Products
Notes
Support
about
terms
$
SLI
STANDARD LITHIUM LTD.
CIK:
0001537137
|
SEC Filings
Income Statement
Cash Flow
Balance Sheet
v3.26.1
Consolidated Statements of Comprehensive (Loss) Income - USD ($)
$ in Thousands
6 Months Ended
12 Months Ended
Dec. 31, 2024
Dec. 31, 2025
Jun. 30, 2024
Expenses
General and administrative
$ 5,472
$ 10,614
$ 16,410
Demonstration Plant operations
1,838
4,464
7,324
Management and directors' fees
986
2,216
2,489
Share-based compensation
2,091
6,589
7,937
Separation benefits
1,295
152
Other
25
Foreign exchange loss (gain)
(316)
3,329
(639)
Loss from operations
11,366
27,389
33,521
Gain on deconsolidation of subsidiaries
164,099
Impairment expense
(19,676)
(26,468)
Investment loss from Smackover Lithium
(707)
(6,358)
(158)
Fair value gain on financial asset - FID
1,052
4,161
391
Fair value gain on Investment in Aqualung
2,742
Interest and other income
232
1,857
922
Interest expense
(27)
(33)
(62)
Net (loss) income before income taxes
(30,492)
(51,488)
131,671
Deferred income tax benefit (expense)
981
3,090
(25,870)
Net (loss) income
(29,511)
(48,398)
105,801
Item that may be reclassified subsequently to income or loss:
Currency translation differences of foreign operations
(562)
3,649
(775)
Total comprehensive (loss) income
$ (30,073)
$ (44,749)
$ 105,026
Weighted average number of common shares outstanding - Basic
185,600,192
206,372,978
176,930,274
Weighted average number of common shares outstanding - Diluted
185,600,192
206,372,978
179,419,385
Basic (loss) earnings per share (in USD per share)
$ (0.16)
$ (0.23)
$ 0.6
Diluted (loss) earnings per share (in USD per share)
$ (0.16)
$ (0.23)
$ 0.59
v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
12 Months Ended
Dec. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
Jun. 30, 2024
Operating activities
Net (loss) income
$ (29,511)
$ (48,398)
$ (1,286)
$ 105,801
Add items not affecting cash
Share-based compensation
2,091
6,589
7,937
Deferred income tax (benefit) expense
(981)
(3,090)
25,870
Unrealized foreign exchange loss (gain)
(316)
3,506
(890)
Impairment expense
19,676
26,468
Gain on deconsolidation of subsidiaries
(164,099)
Investment loss from Smackover Lithium
707
6,358
158
Fair value gain on Investment in Aqualung
(2,742)
Fair value gain on financial asset - FID
(1,052)
(4,161)
(391)
Amortization
603
922
1,142
Interest expense
10
33
62
Other
63
25
Net changes in non-cash working capital items:
Other current assets and receivables
895
(2,485)
(663)
Advances and deposits
21
6
1,934
Accounts payable and accrued liabilities
(4,200)
4,323
5,059
Net cash used in operating activities
(11,994)
(12,646)
(18,080)
Investing activities
Smackover Lithium capital contributions
(29,068)
Exploration and evaluation assets
(2,182)
(22)
(31,596)
Proceeds received from Equinor
30,000
Purchase of property, plant and equipment
(10)
(803)
Change in restricted cash
(173)
(631)
(349)
Patent
(36)
(42)
Net cash used in investing activities
(2,401)
(29,763)
(2,748)
Financing activities
Proceeds from equity offering
0
130,000
Proceeds from at-the-market equity program
6,595
41,009
15,817
Exercise of options
466
2,892
581
Share issuance costs
(203)
(10,008)
(1,226)
Lease payments
(256)
(317)
(470)
Net cash provided by financing activities
6,602
163,576
14,702
Effect of exchange rates on cash
303
(30)
(182)
Net change in cash
(7,490)
121,137
(6,308)
Cash, beginning of period
38,667
31,177
38,667
44,975
Cash, end of period
31,177
152,314
$ 31,177
38,667
Non-cash investing and financing
Change in exploration and evaluation expenditures included in accounts payable
$ 2,030
0
$ 4
Additions to right-of-use assets
134
Change in share issuance costs included in accounts payable
36
Change in proceeds from issuance of shares included in accounts receivable
$ 204
v3.26.1
Consolidated Statements of Financial Position - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Jun. 30, 2024
Current assets
Cash
$ 152,314
$ 31,177
$ 38,667
Restricted cash
1,160
518
345
Other current assets and receivables
4,213
1,610
2,505
Current assets
157,687
33,305
41,517
Non-current assets
Reclamation deposit
63
Exploration and evaluation assets
26,446
45,970
Intangible assets
967
943
985
Right of use asset
257
482
712
Property, plant and equipment
1,036
1,631
1,514
Investment in Aqualung
5,350
2,335
2,500
Investment in Smackover Lithium
168,868
146,158
146,865
Financial asset - FID
52,299
48,138
47,086
Advances and deposits
52
58
79
Non-current assets
228,829
226,191
245,774
TOTAL ASSETS
386,516
259,496
287,291
Current liabilities
Accounts payable and accrued liabilities
9,905
5,501
12,217
Lease liabilities - short-term
181
271
381
Current liabilities
10,086
5,772
12,598
Non-current liabilities
Lease liabilities - long-term
76
206
342
Deferred income tax liabilities
21,799
24,889
25,870
Decommissioning provision
597
572
100
Non-current liabilities
22,472
25,667
26,312
TOTAL LIABILITIES
32,558
31,439
38,910
SHAREHOLDERS' EQUITY
Share capital
405,173
235,782
227,292
Reserves
37,299
36,040
34,781
Accumulated deficit
(86,247)
(37,849)
(8,338)
Accumulated other comprehensive loss
(2,267)
(5,916)
(5,354)
TOTAL SHAREHOLDERS' EQUITY
353,958
228,057
248,381
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY
$ 386,516
$ 259,496
$ 287,291